Iconac Spt Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac, Paracetamol, and Serratiopeptidase. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), provides effective relief from pain and inflammation by inhibiting cyclooxygenase enzymes involved in prostaglandin synthesis. Paracetamol acts as an analgesic and antipyretic, offering symptomatic relief from mild to moderate pain and fever through central inhibition of prostaglandin synthesis. Serratiopeptidase, a proteolytic enzyme, enhances the anti-inflammatory effect by breaking down inflammatory mediators and promoting the resolution of edema and tissue repair. This combination is commonly prescribed for the management of musculoskeletal disorders, postoperative pain, dental pain, and inflammatory conditions such as arthritis. Iconac Spt Tablet is indicated for patients requiring rapid and sustained relief from pain and inflammation, improving functional mobility and quality of life. It should be used under medical supervision, with caution in patients with gastrointestinal ulcers, hepatic or renal impairment, and hypersensitivity to NSAIDs or any component of the formulation. Adverse effects may include gastrointestinal discomfort, allergic reactions, and rarely, hepatic or renal dysfunction. Regular monitoring and adherence to prescribed dosage are essential to minimize risks and optimize therapeutic outcomes.